Information obtained by Buyer and its Representatives in connection with the transactions contemplated by this Agreement shall be subject to the provisions of the Letter Agreement by and between the Company and Magellan Health, Inc., dated as of November 16, 2015 (the “ Confidentiality Agreement ”).  The terms of the Confidentiality Agreement shall survive the termination of this Agreement and continue in full force and effect thereafter and the Confidentiality Agreement shall not be modified, waived or amended without the written consent of the Company.